ASK REDCHAT ANYTHING ABOUT KODIAK SCIENCES INC
Kodiak Sciences Inc (NASDAQ: KOD)
Listen to this Section
$41.27
-0.0400
(
-0.10% )
0.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Tarcocimab (KSI-301) (anti-VEGF)DetailsNon-proliferative diabetic retinopathy |
Phase 3 |
| KSI-501 (anti-VEGF & IL-6)DetailsEye disease , Wet age-related macular degeneration |
Phase 3 |
| KSI-101DetailsEye disease |
Phase 1b |
| KSI-501 (anti-VEGF & IL-6)DetailsDiabetic macular edema, Eye disease |
Phase 1 |
| Tarcocimab (KSI-301)DetailsWet age-related macular degeneration |
Failed |
| Tarcocimab (KSI-301) (anti-VEGF)DetailsDiabetic macular edema |
Failed |
| Tarcocimab (KSI-301)DetailsRetinal vein occlusion |
Failed |
Market Data
|
| Open |
$41.27 |
| Previous Close |
$41.31 |
| Volume |
0.8K |
| Market Cap |
$2.59B |
| Day Range |
$41.52 - $41.93 |
| 52 Week Range |
$4.39 - $47.84 |
| Shares Outstanding |
62.58M |
| Change % |
-0.10% |
| Net Change |
▼ -0.0400 |
| Insider Ownership |
-0.07% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-989,019.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-07 |
Sale |
-334500.00 |
BORGESON JOHN A. |
| 2024-08-07 |
Sale |
-406000.00 |
PERLROTH VICTOR |
| 2024-07-02 |
Sale |
-40000.00 |
BAKER BROS. ADVISORS LP |
| 2024-07-01 |
Sale |
-40000.00 |
Bancroft Charles A |
| 2024-07-01 |
Sale |
-40000.00 |
Dahiyat Bassil I |
| 2024-07-01 |
Sale |
-40000.00 |
PROFUSEK ROBERT |
| 2024-07-01 |
Sale |
-40000.00 |
Yang Taiyin |
| 2024-07-01 |
Sale |
-40000.00 |
Levy Richard S |
| 2024-06-18 |
Sale |
-5494.00 |
BORGESON JOHN A. |
| 2024-06-13 |
Sale |
-3025.00 |
BORGESON JOHN A. |